MoneyWorks4Me

The sales moved up 34.66% to Rs. 585.60 millions for the March 2025 quarter as compared to Rs. 434.86 millions during the year-ago period.The Profit  for the quarter ended March 2025 of  Rs. 65.83  millions  grew by 85.49% from Rs. 35.49 millions.Operating profit for the quarter ended March 2025 rose to 114.84 millions as compared to 51.56 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 585.60 434.86 34.66 2687.16 2087.02 28.76 2687.16 2087.02 28.76
Other Income 27.70 24.87 11.38 81.90 92.79 -11.74 81.90 92.79 -11.74
PBIDT 114.84 51.56 122.73 592.61 323.46 83.21 592.61 323.46 83.21
Interest 2.59 2.17 19.35 9.58 8.14 17.69 9.58 8.14 17.69
PBDT 110.13 49.39 122.98 779.90 315.32 147.34 779.90 315.32 147.34
Depreciation 23.05 4.03 471.96 81.31 16.63 388.94 81.31 16.63 388.94
PBT 87.08 45.36 91.98 698.59 298.69 133.88 698.59 298.69 133.88
TAX 21.25 9.87 115.30 144.98 74.06 95.76 144.98 74.06 95.76
Deferred Tax 8.86 -0.17 -5311.76 9.26 -1.54 -701.30 9.26 -1.54 -701.30
PAT 65.83 35.49 85.49 553.61 224.63 146.45 553.61 224.63 146.45
Equity 132.80 132.19 0.46 132.80 132.19 0.46 132.80 132.19 0.46
PBIDTM(%) 19.61 11.86 65.40 22.05 15.50 42.29 22.05 15.50 42.29
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..